Drug:
Reaction: BLOOD PRESSURE INCREASED
20260101 - 20261231
No. 401 - 500
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 401 | 26879281 |
US |
75 | |
Dyspnoea exertional, Chills, Pruritus, Joint swelling, Blood pressure increased, Pain in jaw, Myalgia, Pain in extremity, Blood glucose increased, Arthralgia, Bone pain, Nausea, Headache, |
||||
TREPROSTINIL, TREPROSTINIL, MACITENTAN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 402 | 26879288 |
US |
71 | |
Pneumonia, Blood pressure increased, Ocular hyperaemia, Hypertension, Productive cough, Wheezing, Rhonchi, Insomnia, Dyspnoea, Cough, Diarrhoea, Epistaxis, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, PANTOPRAZOLE SODIUM, KETOCONAZOLE, KETOCONAZOLE FOAM, KETOCONAZOLE CREAM, 2%, GLIPIZIDE, EMPAGLIFLOZIN, FUROSEMIDE, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, PREDNISONE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, ERGOCALCIFEROL, TADALAFIL, CLOPIDOGREL, CLOPIDOGREL BISULFATE, OXYGEN, 0XYGEN, LOSARTAN POTASSIUM, LOSARTAN, |
||||
| 403 | 26879875 |
US |
61 | |
Blood pressure increased, Sinusitis, |
||||
TIRZEPATIDE, |
||||
| 404 | 26880279 |
MX |
2 | |
Angina pectoris, Back pain, Dysstasia, Movement disorder, Chest pain, Blood pressure increased, Epigastric discomfort, Feeling abnormal, |
||||
NILOTINIB, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, SITAGLIPTIN, |
||||
| 405 | 26880490 |
US |
83 | 2 |
Photopsia, Blood pressure increased, |
||||
CYCLOSPORINE OPHTHALMIC SOLUTION, |
||||
| 406 | 26880638 |
US |
||
Metamorphopsia, Impaired driving ability, Nausea, Dizziness, Blood pressure increased, Vitreous floaters, Vision blurred, |
||||
AFLIBERCEPT, |
||||
| 407 | 26881016 |
CR |
54 | 2 |
Abdominal pain upper, Diarrhoea, Vomiting, Abdominal pain, Muscle spasms, Visual impairment, Blood pressure increased, Urticaria, Pruritus, Hypoacusis, Dyspnoea, Hypoaesthesia, Platelet count decreased, Blood potassium decreased, Blood magnesium decreased, Blood sodium decreased, |
||||
DARATUMUMAB, DARATUMUMAB, |
||||
| 408 | 26875365 |
US |
62 | 2 |
Skin lesion, Injection site pain, Swelling, Injection site bruising, Blood pressure increased, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 409 | 26875790 |
JP |
84 | 1 |
Interstitial lung disease, Blood pressure increased, Heart rate increased, Liver operation, Accidental overdose, Inappropriate schedule of product administration, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 410 | 26873021 |
EU |
20 | 1 |
Multiple sclerosis relapse, Blood pressure increased, |
||||
NATALIZUMAB, |
||||
| 411 | 26873114 |
EU |
53 | 2 |
Serotonin syndrome, Blood pressure increased, Panic attack, Insomnia, Heart rate increased, |
||||
FLUOXETINE HYDROCHLORIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 412 | 26873210 |
PK |
||
Loss of consciousness, Product use in unapproved indication, Dizziness, Blood pressure increased, Blood glucose increased, Asthenia, Arthralgia, Weight increased, |
||||
ORAL SEMAGLUTIDE, ORAL SEMAGLUTIDE, CANDESARTAN CILEXETIL, |
||||
| 413 | 26873497 |
US |
38 | 2 |
Product dose omission issue, Platelet count decreased, Illness, Stress, Vertigo, Malaise, Infection, Product use issue, Blood pressure increased, Fatigue, |
||||
FOSTAMATINIB, FOSTAMATINIB, |
||||
| 414 | 26873511 |
US |
2 | |
Ovarian disorder, Product dose omission issue, Blood pressure increased, |
||||
FOSTAMATINIB, |
||||
| 415 | 26873513 |
US |
2 | |
Headache, Off label use, Limb injury, Blood pressure increased, Dizziness, Nausea, Chest pain, Abdominal pain upper, Diarrhoea, Fatigue, Hypertension, |
||||
FOSTAMATINIB, FOSTAMATINIB, |
||||
| 416 | 26873522 |
CA |
70 | |
Pyoderma gangrenosum, Blood pressure increased, Harvey-Bradshaw index increased, Anal fissure, Decreased appetite, Asthenia, Migraine, Weight decreased, Blister, Oral pain, Cheilitis, Arthralgia, Influenza, Fatigue, Headache, Myalgia, Pruritus, Diarrhoea, Product distribution issue, Intentional dose omission, Product dose omission issue, Off label use, Inappropriate schedule of product administration, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, |
||||
| 417 | 26873609 |
US |
65 | 2 |
Blood pressure fluctuation, Adverse event, Off label use, Balance disorder, Biopsy endometrium, Uterine haemorrhage, Joint swelling, Depressed mood, Blood pressure increased, Dizziness, Fatigue, |
||||
FOSTAMATINIB, FOSTAMATINIB, |
||||
| 418 | 26873613 |
US |
2 | |
Haemoglobin, Blood pressure increased, |
||||
FOSTAMATINIB, |
||||
| 419 | 26873614 |
US |
1 | |
Irritability, Chest discomfort, Anxiety, Platelet count increased, Mean cell haemoglobin, Neutrophil count, Lymphocyte count, Blood pressure increased, Diarrhoea, |
||||
FOSTAMATINIB, FOSTAMATINIB, |
||||
| 420 | 26873645 |
US |
1 | |
Blood pressure increased, |
||||
FOSTAMATINIB, FOSTAMATINIB, |
||||
| 421 | 26873662 |
US |
2 | |
Platelet count, Blood pressure increased, |
||||
FOSTAMATINIB, |
||||
| 422 | 26873669 |
US |
2 | |
Platelet count decreased, Product dose omission issue, Product prescribing issue, Product use issue, Blood pressure increased, Diarrhoea, |
||||
FOSTAMATINIB, FOSTAMATINIB, LOSARTAN POTASSIUM, LOSARTAN, |
||||
| 423 | 26873707 |
US |
77 | 2 |
Diabetes mellitus, Renal disorder, Contusion, Malaise, Pruritus, Insomnia, Tooth loss, Asthenia, Platelet count decreased, Product dose omission issue, Product prescribing issue, Dyspnoea, Neutrophil count decreased, Blood pressure increased, Fatigue, |
||||
FOSTAMATINIB, FOSTAMATINIB, |
||||
| 424 | 26873726 |
US |
60 | 1 |
Platelet disorder, Blood pressure increased, |
||||
FOSTAMATINIB, |
||||
| 425 | 26873741 |
US |
2 | |
Platelet count increased, Platelet count, Fatigue, Blood pressure increased, |
||||
FOSTAMATINIB, |
||||
| 426 | 26873756 |
US |
2 | |
Blood pressure increased, |
||||
FOSTAMATINIB, |
||||
| 427 | 26873759 |
US |
2 | |
Blood pressure increased, |
||||
FOSTAMATINIB, ERGOCALCIFEROL, THYROID, PORCINE, AMLODIPINE, |
||||
| 428 | 26873765 |
US |
2 | |
Blood glucose fluctuation, Platelet count, Skin exfoliation, Systemic lupus erythematosus rash, Dehydration, Blood pressure increased, Hepatic enzyme increased, Diarrhoea, |
||||
FOSTAMATINIB, |
||||
| 429 | 26873808 |
US |
2 | |
Off label use, Blood pressure increased, |
||||
FOSTAMATINIB, |
||||
| 430 | 26873809 |
US |
80 | 1 |
Bronchiectasis, Pseudomonas infection, Bronchial obstruction, Arteriosclerosis coronary artery, Cardiomyopathy, Neuroma, Platelet count decreased, Bronchial wall thickening, Hiatus hernia, Bone density abnormal, Product dose omission issue, Blood pressure increased, |
||||
FOSTAMATINIB, |
||||
| 431 | 26873838 |
US |
1 | |
Tremor, Blood pressure increased, Hepatic enzyme increased, |
||||
FOSTAMATINIB, |
||||
| 432 | 26873852 |
US |
2 | |
Pain, Dehydration, Off label use, Dizziness, Blood pressure increased, Dizziness, |
||||
FOSTAMATINIB, FOSTAMATINIB, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ROMIPLOSTIM, |
||||
| 433 | 26873913 |
US |
1 | |
Blood pressure increased, |
||||
FOSTAMATINIB, LISINOPRIL, MELOXICAM, ROSUVASTATIN, TIMOLOL MALEATE, TIMOLOL MALEATE OPHTHALMIC, VITAMIN C, AMLODIPINE, HYDROCHLOROTHIAZIDE, |
||||
| 434 | 26874023 |
GB |
42 | |
Blood pressure increased, Weight increased, Furuncle, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 435 | 26874115 |
US |
2 | |
Dizziness, Blood pressure increased, |
||||
DUPILUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AMLODIPINE, CYCLOBENZAPRINE, FOLIC ACID, HYDROXYZINE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, GABAPENTIN, CLOPIDOGREL, ROPINIROLE HYDROCHLORIDE, |
||||
| 436 | 26874147 |
US |
2 | |
Blood pressure increased, Rash, |
||||
FOSTAMATINIB, FOSTAMATINIB, AVATROMBOPAG MALEATE, FERROUS SULFATE, FLUOCINONIDE, FLUOCINONIDE TOPICAL SOLUTION USP, 0.05%, RIVAROXABAN, |
||||
| 437 | 26874219 |
US |
2 | |
Blood pressure increased, |
||||
FOSTAMATINIB, |
||||
| 438 | 26874284 |
US |
2 | |
Blood pressure increased, Nausea, Dizziness, |
||||
FOSTAMATINIB, FOLIC ACID, LOPERAMIDE HYDROCHLORIDE, |
||||
| 439 | 26874298 |
US |
2 | |
Platelet count increased, Respiratory disorder, Product prescribing issue, Blood pressure increased, Diarrhoea, Nausea, |
||||
FOSTAMATINIB, FOSTAMATINIB, |
||||
| 440 | 26874301 |
US |
1 | |
Platelet count decreased, Lactose intolerance, Fatigue, Blood pressure increased, |
||||
FOSTAMATINIB, |
||||
| 441 | 26874306 |
US |
1 | |
Pain, Blood pressure increased, |
||||
FOSTAMATINIB, |
||||
| 442 | 26874383 |
US |
1 | |
Parkinson^s disease, Platelet count decreased, Hypoacusis, Blood pressure increased, |
||||
FOSTAMATINIB, CARBIDOPA AND LEVODOPA, |
||||
| 443 | 26874387 |
US |
2 | |
Malaise, Product prescribing issue, Blood pressure increased, |
||||
FOSTAMATINIB, |
||||
| 444 | 26874439 |
US |
1 | |
Platelet count increased, White blood cell count decreased, Pallor, Product dose omission issue, Blood pressure increased, |
||||
FOSTAMATINIB, |
||||
| 445 | 26874452 |
US |
2 | |
Blood pressure increased, |
||||
FOSTAMATINIB, |
||||
| 446 | 26874469 |
US |
1 | |
Platelet count abnormal, Product dose omission issue, Blood pressure increased, |
||||
FOSTAMATINIB, FOSTAMATINIB, |
||||
| 447 | 26874503 |
US |
1 | |
Blood pressure increased, Product dose omission issue, |
||||
FOSTAMATINIB, |
||||
| 448 | 26874507 |
US |
65 | 2 |
Off label use, Cough, Platelet count increased, Chest pain, Blood pressure increased, Diarrhoea, |
||||
FOSTAMATINIB, FOSTAMATINIB, FOSTAMATINIB, |
||||
| 449 | 26874531 |
US |
2 | |
Platelet count decreased, Blood pressure increased, Fatigue, Diarrhoea, |
||||
FOSTAMATINIB, |
||||
| 450 | 26874532 |
US |
2 | |
Peripheral swelling, Off label use, Blood pressure increased, |
||||
FOSTAMATINIB, |
||||
| 451 | 26874574 |
US |
33 | 1 |
Platelet count, Bone pain, Abdominal distension, Flatulence, Blood pressure increased, Alanine aminotransferase increased, Aspartate aminotransferase increased, |
||||
FOSTAMATINIB, |
||||
| 452 | 26874581 |
US |
2 | |
Blood pressure increased, |
||||
FOSTAMATINIB, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 453 | 26874600 |
US |
2 | |
Platelet count, Platelet count increased, Fatigue, Dizziness, Blood pressure increased, |
||||
FOSTAMATINIB, |
||||
| 454 | 26874608 |
US |
2 | |
Blood pressure increased, |
||||
FOSTAMATINIB, PREDNISONE, |
||||
| 455 | 26874614 |
US |
1 | |
Laboratory test abnormal, Blood pressure increased, Diarrhoea, |
||||
FOSTAMATINIB, FOSTAMATINIB, FOSTAMATINIB, |
||||
| 456 | 26874669 |
US |
1 | |
Hypoaesthesia, Asthenia, Muscular weakness, Muscle spasms, Pain, Depressed mood, Loss of personal independence in daily activities, Blood pressure increased, |
||||
FOSTAMATINIB, |
||||
| 457 | 26874769 |
US |
2 | |
Platelet count decreased, Renal impairment, Hyperhidrosis, Thirst, Contusion, Dry mouth, Blood pressure increased, Dizziness, Diarrhoea, |
||||
FOSTAMATINIB, FOSTAMATINIB, |
||||
| 458 | 26874792 |
US |
1 | |
Platelet count decreased, Platelet count, Platelet count, Asthenia, Blood glucose increased, Flatulence, Abdominal distension, Abdominal tenderness, Blood glucose increased, Abdominal pain upper, Rash erythematous, Diarrhoea, Blood pressure increased, |
||||
FOSTAMATINIB, FOSTAMATINIB, FOSTAMATINIB, |
||||
| 459 | 26874802 |
US |
1 | |
Neutropenia, Blood pressure increased, |
||||
FOSTAMATINIB, |
||||
| 460 | 26874807 |
US |
1 | |
Blood pressure increased, |
||||
FOSTAMATINIB, |
||||
| 461 | 26874820 |
US |
2 | |
Blood pressure increased, |
||||
FOSTAMATINIB, |
||||
| 462 | 26874850 |
US |
1 | |
Blood pressure increased, |
||||
FOSTAMATINIB, |
||||
| 463 | 26874871 |
US |
2 | |
Urinary tract infection, Macrocytosis, Blood pressure increased, |
||||
FOSTAMATINIB, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, MIRABEGRON, |
||||
| 464 | 26874935 |
US |
1 | |
Gait disturbance, Illness, Adverse event, Dizziness, Diarrhoea, Blood pressure increased, |
||||
FOSTAMATINIB, FOSTAMATINIB, TRANEXAMIC ACID, |
||||
| 465 | 26874971 |
US |
2 | |
Gastrointestinal disorder, Blood pressure increased, |
||||
FOSTAMATINIB, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, ELTROMBOPAG, ELTROMBOPAG OLAMINE, SACUBITRIL AND VALSARTAN, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, FLUTICASONE PROPIONATE, ALENDRONATE SODIUM, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, METOPROLOL SUCCINATE, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, |
||||
| 466 | 26874986 |
US |
2 | |
Product dose omission issue, Blood pressure increased, |
||||
FOSTAMATINIB, |
||||
| 467 | 26874996 |
GB |
2 | |
Blood pressure increased, Ear discomfort, |
||||
DAPAGLIFLOZIN, LATANOPROST, |
||||
| 468 | 26868142 |
US |
45 | |
Blood pressure increased, |
||||
EPTINEZUMAB-JJMR, ATOGEPANT, |
||||
| 469 | 26868143 |
US |
73 | 1 |
Mouth ulceration, Oral pain, Feeding disorder, Dehydration, Blood pressure increased, Suspected off label use, |
||||
REGORAFENIB, FRUQUINTINIB, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, MEGESTROL ACETATE, |
||||
| 470 | 26868344 |
US |
63 | 2 |
Headache, Muscle spasms, Diarrhoea, Fatigue, Blood pressure increased, Blood cholesterol increased, |
||||
| 471 | 26868542 |
US |
87 | 1 |
Parkinson^s disease, Blood pressure increased, Flushing, On and off phenomenon, Gait inability, Somnolence, Anxiety, Dyspnoea, Dizziness, Drug ineffective, |
||||
ENALAPRIL, |
||||
| 472 | 26868779 |
US |
81 | 2 |
Blood pressure increased, Vision blurred, Palpitations, Nausea, Somnolence, Fall, Headache, Chest discomfort, Adverse event, Nausea, Vomiting, Anxiety, Hallucination, |
||||
ACETAMINOPHEN, DEXTROMETHORPHAN HBR, ACETAMINOPHEN AND DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN AND CAFFEINE, ACETAMINOPHEN AND PHENYLEPRINE HCL, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HBR, ACETAMINOPHEN, DEXTROMETHORPHAN HBR, ACETAMINOPHEN AND DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN AND CAFFEINE, ACETAMINOPHEN AND PHENYLEPRINE HCL, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HBR, |
||||
| 473 | 26868913 |
US |
77 | |
Blood pressure increased, Vomiting, Cough, Flushing, Hypotension, Dizziness, Nausea, Fatigue, Malaise, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, CYCLOBENZAPRINE, LEVOTHYROXINE SODIUM, ERGOCALCIFEROL, MACITENTAN, EZETIMIBE, BIOTIN, EVOLOCUMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, FUROSEMIDE, OXYGEN, 0XYGEN, |
||||
| 474 | 26869172 |
US |
44 | 2 |
Epistaxis, Blood pressure increased, |
||||
IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, NAPROXEN, NAPROXEN SODIUM, LEVOKETOCONAZOLE, |
||||
| 475 | 26869232 |
CN |
||
Blood pressure increased, |
||||
ACALABRUTINIB, |
||||
| 476 | 26869630 |
CA |
75 | |
Blood pressure increased, Fear of injection, Increased appetite, Weight increased, Bone pain, Dyspnoea, Depression, Anxiety, Peripheral swelling, Urticaria, Myalgia, Headache, Injection site reaction, Inappropriate schedule of product administration, Suspected off label use, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, BETAMETHASONE VALERATE, BETAMETHASONE VALERATE FOAM, FAMOTIDINE, PREDNISONE, VITAMIN C, |
||||
| 477 | 26869839 |
US |
85 | 2 |
Gout, Hypotension, Electrolyte imbalance, Headache, Blood pressure increased, Dysstasia, Drug ineffective, |
||||
PEGLOTICASE, PEGLOTICASE, PEGLOTICASE, PREDNISONE, |
||||
| 478 | 26870189 |
CA |
60 | 1 |
Blood pressure increased, Constipation, Feeling cold, Arthralgia, Dizziness, Hot flush, Injection site swelling, Loss of consciousness, Neuropathy peripheral, Eye pain, Asthenia, Pain in extremity, Unevaluable event, Anxiety, Visual impairment, Diabetes mellitus, |
||||
LEUPROLIDE ACETATE, |
||||
| 479 | 26870375 |
US |
59 | 2 |
Blood pressure increased, |
||||
SARILUMAB, SODIUM OXYBATE, SODIUM OXYBATE, SODIUM OXYBATE, |
||||
| 480 | 26870504 |
US |
77 | |
Blood pressure increased, Dyspnoea exertional, Chest discomfort, Cough, Throat irritation, Dyspnoea, Head discomfort, Headache, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, AZATHIOPRINE, ROSUVASTATIN CALCIUM, NINTEDANIB, AMLODIPINE BESYLATE, VALSARTAN, VALSARTAN ORAL, CARVEDILOL, DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN, DEXTROMETHORPHAN, ACETAMINOPHEN AND DEXTROMETHORPHAN HYDROBROMIDE, NAPROXEN SODIUM, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, GUAIFENESIN, NAPROXEN SODIUM, PSEUDOEPHEDRINE HYDROCHLORIDE, |
||||
| 481 | 26870522 |
US |
74 | |
Dehydration, Blood pressure increased, Listless, Eye pruritus, Malaise, Drug ineffective, Headache, Dyspnoea, Fatigue, Cough, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, MELOXICAM, PANTOPRAZOLE SODIUM, FISH OIL, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, LOSARTAN POTASSIUM, LOSARTAN, DULOXETINE HYDROCHLORIDE, DULOXETINE, SILDENAFIL CITRATE, SILDENAFIL, CLOPIDOGREL, CLOPIDOGREL BISULFATE, SPIRONOLACTONE, LEVOTHYROXINE SODIUM, ERGOCALCIFEROL, AMLODIPINE BESYLATE, FUROSEMIDE, MAGNESIUM, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, VITAMIN C, |
||||
| 482 | 26870526 |
US |
55 | |
Cardiac valve disease, Ear discomfort, Blood pressure increased, Cough, Headache, Hypotension, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, MACITENTAN, SILDENAFIL CITRATE, SILDENAFIL, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ACETAMINOPHEN, |
||||
| 483 | 26870568 |
US |
80 | |
Inspiratory capacity decreased, Salivary hyposecretion, Blood pressure increased, Blood pressure fluctuation, Throat irritation, |
||||
TREPROSTINIL, TREPROSTINIL, CETIRIZINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE, RIVAROXABAN, FINASTERIDE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, AMIODARONE HYDROCHLORIDE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, OXYGEN, 0XYGEN, DIGOXIN, RASAGILINE MESYLATE, |
||||
| 484 | 26870812 |
US |
61 | 2 |
Cataract, Cytopenia, Herpes zoster, Double stranded DNA antibody positive, Feeling cold, Musculoskeletal stiffness, Peripheral swelling, Oedema peripheral, Arthralgia, Catheterisation cardiac, Proteinuria, Complement factor C3 decreased, Complement factor C4 decreased, Skin discolouration, Arteriosclerosis, Cryoglobulins present, Diarrhoea, Nausea, Blood pressure increased, Decreased appetite, Glomerular filtration rate decreased, Fatigue, Absence of immediate treatment response, |
||||
VOCLOSPORIN, VOCLOSPORIN, VOCLOSPORIN, VOCLOSPORIN, VOCLOSPORIN, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, CLOPIDOGREL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ROSUVASTATIN, |
||||
| 485 | 26870931 |
US |
1 | |
Blood pressure increased, Abdominal pain upper, |
||||
UPADACITINIB, |
||||
| 486 | 26870962 |
US |
74 | 2 |
Blood pressure increased, Urinary tract infection, Blood magnesium decreased, Disorientation, |
||||
LENVATINIB, |
||||
| 487 | 26871059 |
US |
2 | |
Anaphylactic reaction, Chills, Blood pressure increased, |
||||
TIRZEPATIDE, |
||||
| 488 | 26871250 |
US |
||
Blood pressure increased, Product administered to patient of inappropriate age, |
||||
ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, IBUPROFEN, IBUPROFEN AND DIPHENHYDRAMINE CITRATE, NAPROXEN SODIUM, NAPROXEN SODIUM TABLET, |
||||
| 489 | 26871402 |
US |
||
Myocardial infarction, Blood pressure increased, |
||||
CETIRIZINE HYDROCHLORIDE, |
||||
| 490 | 26871425 |
CN |
61 | 1 |
Syncope, Hypotension, Blood pressure increased, Off label use, |
||||
SACUBITRIL AND VALSARTAN, SACUBITRIL AND VALSARTAN, |
||||
| 491 | 26871525 |
CN |
60 | 1 |
Hypokalaemia, Myelosuppression, Febrile infection, Blood pressure increased, Erythema, Skin swelling, Hyperuricaemia, Hyperlipidaemia, Hypocalcaemia, Hypomagnesaemia, Blood lactate dehydrogenase increased, Pyrexia, Suspected off label use, |
||||
ELRANATAMAB-BCMM, ELRANATAMAB-BCMM, ELRANATAMAB-BCMM, ELRANATAMAB-BCMM, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, RABEPRAZOLE, SODIUM BICARBONATE, SODIUM BICARBONATE, INJECTION, SODIUM BICARBONATE INJECTION,, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 492 | 26871590 |
US |
48 | 2 |
Blood pressure increased, Hypersensitivity, |
||||
NATALIZUMAB, |
||||
| 493 | 26872101 |
68 | 2 | |
Hepatitis, Decreased appetite, Nausea, Dizziness, Gait disturbance, Alopecia, Depression, Memory impairment, Blood pressure increased, |
||||
FAM-TRASTUZUMAB DERUXTECAN-NXKI, PEGFILGRASTIM, APREPITANT, APREPITANT, APREPITANT, |
||||
| 494 | 26872378 |
US |
57 | 1 |
Blood pressure increased, Antiphospholipid syndrome, Contraindicated product administered, Neck pain, |
||||
MYCOPHENOLIC ACID, MYCOPHENILIC ACID, NICOTINE, ATORVASTATIN CALCIUM, HYDROXYZINE, NAPROXEN, NAPROXEN SODIUM, HYDROXYCHLOROQUINE, PREDNISONE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ERGOCALCIFEROL, CYCLOBENZAPRINE, |
||||
| 495 | 26872631 |
US |
2 | |
Diabetes mellitus, Insurance issue, Product use issue, Blood pressure increased, Weight decreased, |
||||
HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, |
||||
| 496 | 26872761 |
CA |
78 | 1 |
Ageusia, Dysphagia, Stoma site infection, Rash, Paraesthesia, Hypophagia, Weight decreased, Decreased appetite, Skin disorder, Pain, Nasal dryness, Metastases to bone, Calculus urinary, Dehydration, Heart rate increased, Dry mouth, Dry skin, Fatigue, Constipation, Heart rate decreased, Tongue ulceration, Urosepsis, Nausea, Alopecia, Bell^s palsy, Papule, Blood pressure increased, Off label use, Paraesthesia, Hypoacusis, Oral fungal infection, Blood pressure systolic decreased, |
||||
PEMBROLIZUMAB, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, DIMENHYDRINATE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 497 | 26872821 |
US |
81 | 2 |
Hospitalisation, Blood pressure increased, Lymphadenopathy, Dysphagia, Sensation of foreign body, Gait disturbance, Blood pressure fluctuation, Dry mouth, Dizziness, Hypertension, |
||||
PRALSETINIB, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, HYDROCORTISONE, MAGNESIUM, DORZOLAMIDE, ESTRADIOL, ERGOCALCIFEROL, LATANOPROST, LOSARTAN, NIFEDIPINE, BROMFENAC SODIUM, LEVOTHYROXINE SODIUM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, CAMPHOR (SYNTHETIC), EUCALYPTUS OIL, MENTHOL, CAMPHOR (SYNTHETIC), EUCALYPTUS OIL, AND MENTHOL, DICLOFENAC SODIUM, ALPRAZOLAM, AMMONIUM LACTATE, FEXOFENADINE HYDROCHLORIDE, |
||||
| 498 | 26878598 |
77 | 2 | |
Blood pressure increased, |
||||
| 499 | 26862973 |
US |
62 | 2 |
Blood pressure increased, Headache, Rhinorrhoea, |
||||
EVOLOCUMAB, |
||||
| 500 | 26864193 |
US |
51 | 2 |
Apnoea, Blood gases abnormal, Cardiac disorder, Hypopnoea, Feeling abnormal, Erythema, Mast cell activation syndrome, Flushing, Muscle rigidity, Hyperhidrosis, Blood pressure increased, Drug ineffective, |
||||
SODIUM OXYBATE, SODIUM OXYBATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, THYROID, PORCINE, GLYCINE, ACETYLCYSTEINE, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30